FIELD: medicine.
SUBSTANCE: invention relates to an improved gelatine-coated unit dosage form with two gelatine-coated ends and an open ring holed at least once to uncover the core material. Besides, the invention concerns the methods for manufacturing said gelatine-coated unit dosage forms.
EFFECT: unit dosage form according to the invention has improved dissolution and disintegration as compared to commercially available gelatine-coated products.
29 cl, 3 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMERSION COATING COMPOSITIONS CONTAINING HIGH AMYLOSE STARCH | 2009 |
|
RU2486917C2 |
| ACETAMINOPHEN/IBUPROFEN COMBINATIONS | 2007 |
|
RU2465897C2 |
| QUICK DESTROYING COATED TABLET | 2013 |
|
RU2609836C2 |
| DOSED FORM OF IMMEDIATE RELEASE CONTAINING COAT WITH HOLES | 2005 |
|
RU2391092C2 |
| SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS | 2008 |
|
RU2471480C2 |
| FORM OF PROLONGED VENLAFAXINE HYDROCHLORIDE LIBERATION | 2004 |
|
RU2340331C2 |
| DOSAGE FORM OF ORALLY DISINTEGRATING TWO-PIECE TABLET | 2008 |
|
RU2466719C2 |
| LAYERS FOR MECHANICAL PROTECTION OF SOLID DOSAGE FORMS | 2008 |
|
RU2500389C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
| LACTOSE-FREE, NONHYGROSCOPIC AND ANHYDROUS PHARMACEUTICAL PREPARATIONS OF DESCARBOETHOXYLORATADINE | 1998 |
|
RU2209627C2 |
